-
Name
Ipratropium Bromide Inhalation Solution
-
approval number
National Medicine Approval No. H20255525
-
norm
2ml: 0.25mg (calculated as C20H30BrNO3)
-
Packaging specification
5 pieces/bag, 2 bags/box, 4 bags/box, 6 bags/box
-
indications
This product can be used in combination with inhaled beta agonists to treat reversible airway obstruction caused by acute or chronic asthma.